MarketLens

Pricing Plans Sign Up Log in

Stock Analysis Pro

What's Behind Corcept's Recent Legal Troubles

3 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

What's Behind NuScale Power's Recent Volatility and Legal Troubles

3 months ago

What Triggered Kyndryl's Recent Stock Plunge and Legal Troubles

3 months ago

What's Behind Paysafe's Latest Legal Headwinds

2 months ago

What Does Peloton's Recent Legal Victory Signify for Investors

1 months ago

CORT to Resubmit NDA for Relacorilant in Cushing's Syndrome, Stock Up

Corcept Therapeutics shares rose following the company's announcement to resubmit its New Drug Application (NDA) for relacorilant. The treatment targets Cushing's syndrome, marking a key regulatory mi...

CORT

Stock News•3 days ago

J&J Mastered Cancer Biotech Deals on the Cheap. Can It Stay on the Cutting Edge?

Johnson & Johnson’s reliance on a partnership-heavy biotech strategy has secured cost-effective drug assets, but analysts warn the approach may leave the company exposed to pipeline gaps. The firm now...

JNJ

Stock News•2 weeks ago

Corvus Pharmaceuticals, Inc. (CRVS) Shareholder/Analyst Call Transcript

Corvus Pharmaceuticals (CRVS) held a shareholder and analyst call to discuss recent corporate developments. The session provided updates on the company's clinical pipeline and operational progress, of...

CRVS

Stock News•3 weeks ago

Securities Fraud Investigation Into Cencora, Inc. (COR) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz launched a securities fraud investigation into Cencora, Inc. (COR) following the company's May 6, 2026, second-quarter financial results.

COR